Samsung Biologics Exec Jo Seong-hwan Withdraws 50 Shares from ESOP
Samsung Biologics Managing Director Jo Seong-hwan (non-registered executive) withdrew 50 common shares from the employee stock ownership account to his personal account
Post-withdrawal holding is 50 shares (0.00%), negligible relative to total outstanding shares of 46,290,951
KOSPI Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders